title: Reversible lansoprazole-induced interstitial lung disease showing improvement after drug cessation.
abstract: Lansoprazole is an acid proton-pump inhibiting drug that is used for the treatment of duodenal or gastric ulcers, H. pylori infection, gastroesophageal reflux disease or Zollinger-Ellison syndrome. Although lansoprazole is well known for its gastrointestinal and dermatologic adverse effects, mild pulmonary symptoms are also known to develop from taking this drug. There have been no reports about lansoprazole-induced interstitial lung disease. We report here a case of lansoprazole-induced interstitial lung disease that developed in a 66-year-old man.
authors.affiliation: Department of Radiology, College of Medicine, Korea University, Guro Hospital, Seoul, Korea. wokhee@unitel.co.kr.
authors.forename: Kyu-won
authors.initials: KW
authors.lastname: Hwang
authors.forename: Ok Hee
authors.initials: OH
authors.lastname: Woo
authors.forename: Hwan Seok
authors.initials: HS
authors.lastname: Yong
authors.forename: Bong Kyung
authors.initials: BK
authors.lastname: Shin
authors.forename: Jae Jeong
authors.initials: JJ
authors.lastname: Shim
authors.forename: Eun-Young
authors.initials: EY
authors.lastname: Kang
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000009:adverse effects*; D000368:Aged; D000897:Anti-Ulcer Agents / Q000009:adverse effects*; D001706:Biopsy / Q000379:methods; D005764:Gastroesophageal Reflux / Q000188:drug therapy; D006801:Humans; D064747:Lansoprazole; D008168:Lung / Q000473:pathology*; D017563:Lung Diseases, Interstitial / Q000139:chemically induced*; D008297:Male; D020775:Thoracic Surgery, Video-Assisted; D014057:Tomography, X-Ray Computed
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D064747:Lansoprazole